Rabies Immune Globulin

What is Rabies Immune Globulin?

Rabies Immune Globulin (RIG) is a critical medication used in the immediate prevention of rabies after a suspected exposure. Unlike the rabies vaccine, which stimulates the body to produce its own antibodies over time, RIG provides immediate, temporary passive immunity by supplying pre-formed antibodies directly to the patient. These antibodies are designed to neutralize the rabies virus at the site of the exposure before it can spread throughout the body.

RIG is typically derived from human plasma (Human Rabies Immune Globulin or HRIG) from donors who have been hyper-immunized against rabies, or less commonly, from equine (horse) sources. Its primary role is to offer rapid protection, acting as a crucial bridge until the individual's own immune system can mount a protective response from the concurrently administered rabies vaccine.

How Does it Work?

The mechanism of action for Rabies Immune Globulin is straightforward yet vital. When a person is exposed to the rabies virus, for instance, through an animal bite or scratch, there's a critical window before the virus can establish infection in the nervous system. RIG contains a high concentration of specific antibodies (immunoglobulins) that are capable of recognizing and binding to the rabies virus.

Upon administration, these antibodies infiltrate the tissues around the wound site where the virus may have entered. By binding to the virus particles, they effectively neutralize them, preventing the virus from replicating and spreading. This immediate action is crucial because the rabies vaccine takes several days or weeks to induce a protective immune response. RIG provides immediate protection, buying time for the body's active immunity to develop, thereby significantly reducing the risk of developing rabies, which is almost invariably fatal once symptoms appear.

Medical Uses

The sole and paramount medical use of Rabies Immune Globulin is for rabies post-exposure prophylaxis (PEP). This means it is administered after a person has been potentially exposed to the rabies virus. Indications for RIG administration typically include:

• Bites or Scratches: Any penetration of the skin by an animal suspected or confirmed to have rabies.
• Mucous Membrane Exposure: Contamination of the eyes, nose, or mouth with saliva or neural tissue from a rabid animal.
• Open Wounds: Licking of pre-existing open wounds or broken skin by a rabid animal.

RIG is almost always given in conjunction with a series of rabies vaccine doses to individuals who have not been previously vaccinated against rabies. In certain circumstances, even previously vaccinated individuals may require RIG, depending on the nature and severity of their exposure and their vaccination history. It is a critical component of preventing rabies, especially in high-risk exposures where prompt action is essential.

Dosage

The dosage of Rabies Immune Globulin is calculated based on the patient's body weight. For Human Rabies Immune Globulin (HRIG), the standard dose is 20 International Units (IU) per kilogram of body weight. The administration method is highly specific and crucial for its effectiveness:

• Wound Infiltration: As much of the calculated dose as anatomically feasible should be thoroughly infiltrated into and around the wound site(s). This direct application ensures that antibodies are present where the virus is most likely to be.
• Intramuscular Injection: Any remaining portion of the calculated dose, after wound infiltration, should be administered intramuscularly at a site distant from the rabies vaccine injection site (e.g., gluteal region or anterolateral thigh).

RIG should be administered as soon as possible after exposure, ideally at the same time as the first dose of rabies vaccine. While there is no strict time limit, its effectiveness significantly decreases if given more than 7 days after the first dose of vaccine, as by then, the body's own immune response to the vaccine should be developing. It is vital that a healthcare professional determines the appropriate dosage and administration based on individual circumstances and current guidelines.

Side Effects

Like all medications, Rabies Immune Globulin can cause side effects, although serious reactions are rare. Most side effects are mild and transient:

• Local Reactions: The most common side effects occur at the injection site and include pain, soreness, redness, swelling, or tenderness.
• Systemic Reactions: Less commonly, individuals may experience mild systemic symptoms such as low-grade fever, headache, malaise (general feeling of discomfort), or chills.
• Allergic Reactions: Mild allergic reactions like rash or itching can occur. Severe allergic reactions, including anaphylaxis, are very rare but possible. Healthcare providers are prepared to manage such emergencies.

Individuals with a history of severe allergic reactions to human immunoglobulin products or those with IgA deficiency may require special precautions or alternative treatments. Patients should inform their doctor about any allergies or pre-existing medical conditions before receiving RIG. It's important to report any unusual or severe symptoms to a healthcare professional immediately.

Drug Interactions

When considering drug interactions for Rabies Immune Globulin, the primary concern revolves around its potential to interfere with the immune response to other live virus vaccines. Because RIG provides passive antibodies, it can transiently suppress the immune response to concurrently administered live attenuated virus vaccines, such as those for measles, mumps, and rubella (MMR), or varicella (chickenpox).

Therefore, it is generally recommended to defer the administration of live virus vaccines for at least 3 months after receiving Rabies Immune Globulin. This allows the passively acquired antibodies to clear from the system, ensuring the live vaccine can induce a robust and lasting immune response. It's crucial to note that RIG does not interfere with the immune response to the inactivated rabies vaccine, which is given concurrently. There are generally no significant interactions with other common medications. Always inform your healthcare provider about all medications, supplements, and vaccines you are taking or have recently received.

FAQ

Q: Is Rabies Immune Globulin the same as the rabies vaccine?

A: No, they are different. Rabies Immune Globulin provides immediate, temporary antibodies (passive immunity), while the rabies vaccine stimulates your body to produce its own long-lasting antibodies (active immunity).

Q: How soon after exposure should RIG be given?

A: RIG should be administered as soon as possible after a potential exposure, ideally at the same time as the first dose of the rabies vaccine. Its effectiveness diminishes if given more than 7 days after the first vaccine dose.

Q: Can I get rabies even after receiving RIG and the vaccine?

A: While highly effective, no medical intervention offers 100% guarantee. However, the combination of RIG and the rabies vaccine series, administered promptly and correctly, is extremely effective in preventing rabies after exposure. Failures are exceedingly rare and often linked to delays in treatment or improper administration.

Q: Are there different types of Rabies Immune Globulin?

A: Yes, the most common type used in humans is Human Rabies Immune Globulin (HRIG), derived from human plasma. Equine Rabies Immune Globulin (ERIG), derived from horses, is used in some regions but carries a higher risk of allergic reactions.

Q: Who should not receive Rabies Immune Globulin?

A: Generally, RIG is contraindicated in individuals with a known severe allergic reaction to human immunoglobulin products. It is also not typically given to individuals who have completed a full pre-exposure or post-exposure rabies vaccination series and have documented adequate antibody titers, as their own immune system is already primed.

Products containing Rabies Immune Globulin are available through trusted online pharmacies. You can browse Rabies Immune Globulin-based medications at ShipperVIP or Medicenter.

Summary

Rabies Immune Globulin is an indispensable component of rabies post-exposure prophylaxis, offering immediate, crucial protection against the deadly rabies virus. By supplying pre-formed antibodies, it neutralizes the virus at the site of exposure, bridging the gap until the body can develop its own active immunity from the concurrently administered rabies vaccine. While generally safe, with most side effects being mild and localized, its timely and proper administration is paramount to preventing a fatal outcome after a suspected exposure. Anyone who suspects they have been exposed to the rabies virus through an animal bite or other means should seek immediate medical attention to receive appropriate treatment, including Rabies Immune Globulin and the rabies vaccine series.